But... they don't have to lower the price back to what it was?
So... how is this anything more than the government getting a taste of the spoils fleeced from gouging people who need medical care?
I fail to see what good this does, seems to just incentivize the company to make back another $465M by raising the price again soon as the media hype is over.
Different issues. Issue 1, Epipens cost $300 now instead of $50. Issue 2, Mylan was saying they were generics and getting $261 from the government when in reality, they were brand name and the government should have only been paying $231. This settlement is about issue 2 and they have said they will correct this practice, issue 1 is unrelated.
So... how is this anything more than the government getting a taste of the spoils fleeced from gouging people who need medical care?
I fail to see what good this does, seems to just incentivize the company to make back another $465M by raising the price again soon as the media hype is over.